Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

Original Article

L.A. Castellucci, V.M. Chen, M.J. Kovacs, A. Lazo-Langner, P. Greenstreet, S. Kahn, B. Côté, S. Schulman, K.d. Wit, J. Douketis, D. Suryanarayan, T. Wan, E. Yeo, G.L. Templier, H.A. Tran, A. Willcox, H.J. Crowther, R. Prasad, S. Shivakumar, E. Umana, F.N. Ainle, T. Tritschler, S. Barco, J.-P. Galanaud, M. Blondon, L.B. Kreuziger, S. Solymoss, C. Kearon, E. Thomas, T. Ramsay, G.L. Gal, and M. Rodger

N Engl J Med 2026;394:1051-1060

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
03/11/2026
Course expires: 
03/12/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.